GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » Cyclically Adjusted PB Ratio

3B BlackBio Dx (BOM:532067) Cyclically Adjusted PB Ratio : 7.65 (As of Jun. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx Cyclically Adjusted PB Ratio?

As of today (2024-06-06), 3B BlackBio Dx's current share price is ₹852.05. 3B BlackBio Dx's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹111.34. 3B BlackBio Dx's Cyclically Adjusted PB Ratio for today is 7.65.

The historical rank and industry rank for 3B BlackBio Dx's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:532067' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.55   Med: 7.26   Max: 13.16
Current: 7.65

During the past years, 3B BlackBio Dx's highest Cyclically Adjusted PB Ratio was 13.16. The lowest was 4.55. And the median was 7.26.

BOM:532067's Cyclically Adjusted PB Ratio is ranked worse than
86.08% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs BOM:532067: 7.65

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

3B BlackBio Dx's adjusted book value per share data for the three months ended in Mar. 2024 was ₹259.884. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹111.34 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


3B BlackBio Dx Cyclically Adjusted PB Ratio Historical Data

The historical data trend for 3B BlackBio Dx's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx Cyclically Adjusted PB Ratio Chart

3B BlackBio Dx Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 7.05 5.66 4.98 6.91

3B BlackBio Dx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.98 - 7.97 - 6.91

Competitive Comparison of 3B BlackBio Dx's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, 3B BlackBio Dx's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's Cyclically Adjusted PB Ratio falls into.



3B BlackBio Dx Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

3B BlackBio Dx's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=852.05/111.34
=7.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3B BlackBio Dx's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, 3B BlackBio Dx's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=259.884/153.0345*153.0345
=259.884

Current CPI (Mar. 2024) = 153.0345.

3B BlackBio Dx Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 94.103 0.000
201409 15.800 96.780 24.984
201412 0.000 96.780 0.000
201503 15.773 97.163 24.843
201506 0.000 99.841 0.000
201509 16.074 101.753 24.175
201512 0.000 102.901 0.000
201603 16.262 102.518 24.275
201606 0.000 105.961 0.000
201609 17.438 105.961 25.185
201612 0.000 105.196 0.000
201703 17.493 105.196 25.448
201706 0.000 107.109 0.000
201709 20.322 109.021 28.526
201712 0.000 109.404 0.000
201803 28.690 109.786 39.992
201806 0.000 111.317 0.000
201809 32.377 115.142 43.032
201812 0.000 115.142 0.000
201903 35.118 118.202 45.467
201906 0.000 120.880 0.000
201909 40.206 123.175 49.953
201912 0.000 126.235 0.000
202003 42.770 124.705 52.486
202006 0.000 127.000 0.000
202009 144.433 130.118 169.871
202012 0.000 130.889 0.000
202103 175.879 131.771 204.261
202106 0.000 134.084 0.000
202109 191.286 135.847 215.488
202112 0.000 138.161 0.000
202203 203.813 138.822 224.680
202206 0.000 142.347 0.000
202209 213.946 144.661 226.330
202212 0.000 145.763 0.000
202303 228.055 146.865 237.636
202306 0.000 150.280 0.000
202309 277.503 151.492 280.329
202312 0.000 152.924 0.000
202403 259.884 153.035 259.884

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


3B BlackBio Dx  (BOM:532067) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


3B BlackBio Dx Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines